Article Date: 01 Feb 2006 - 23:00pm (UK)
The initial results of two of the “Sequenced Treatment Enhancement Program for Bipolar Disorder” (STEP-BD) studies are being released in the February 2006 edition of the AMERICAN JOURNAL OF PSYCHIATRY (AJP), the official journal of the American Psychiatric Association (APA).
The AJP article, “Predictors of Recurrence in Bipolar Disorder: Primary Outcomes From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)” authored by Roy H. Perlis, M.D., evaluates 1469 participants who were in the trial for up to two years. The study reports that 58 percent of participants experienced a significant period of recovery in response to evidence-based treatment for Bipolar Disorder including contemporary medications and psychosocial interventions. However, about half of the recovered patients had recurrences during the following two years. More…
A companion AJP article, “Treatment-Resistant Bipolar Depression: A STEP-BD Equipoise Randomized Effectiveness Trial of Antidepressant Augmentation With Lamotrigine, Inositol, or Risperidone” led by Andrew A. Nierenberg, M.D., compares three possible supplementary treatments for those patients who have treatment-resistant bipolar depression and finds some advantages for lamotrigine as an addition to other mood stabilizers and antidepressants. More…
Article provided by Medical News Today
- 14
- Feb, 08









